CoreAge Rx vs Alinwell
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Alinwell head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Alinwell a bad call — it's best for readers seeking direct clinician messaging who can obtain the full payment commitment and pharmacy details before enrollment. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Alinwell |
|---|---|---|
| Brief Score | 94/100 (A) | 66/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm the full plan Advertised from $139/month; full commitment and supplied quantity are not established. Terms describe thirty-day renewals; confirm the selected first payment and cancellation deadline. Full price detailsCompounded semaglutide offered; complete selected-term quote unknown; homepage advertises from $139/month without the full commitment or supplied quantity |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm the full plan Advertised from $166/month; full commitment and supplied quantity are not established. Terms describe thirty-day renewals; confirm the selected first payment and cancellation deadline. Full price detailsCompounded tirzepatide offered; complete selected-term quote unknown; homepage advertises from $166/month without the full commitment or supplied quantity |
| Coverage | US only; restrictions by state, confirmed at intake | Advertises nationwide telehealth; exact treatment-state eligibility must be confirmed with the assigned independent clinician |
| Brand-name access | Not confirmed | Reviewed named GLP-1 plans are compounded; branded fulfillment was not established. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Alinwell: From $139/$166 monthly is a starting advertisement. Confirm the full term, supplied quantity and first charge; renewals are described as every thirty days.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.